Goki Suda

49PUBLICATIONS
90CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGastroenterology and hepatologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Sep 11, 2026
Serum Leucine-Rich α2-Glycoprotein 1 Identifies Cachexia in Patients With Liver Cirrhosis and/or Hepatocellular Carcinoma Having Low C-Reactive Protein Levels.

|Jul 06, 2026
Circulating cfDNA CD86 methylation is associated with durable response to atezolizumab-bevacizumab in hepatocellular carcinoma.

|Jun 26, 2026
Alcohol involvement may modify the association between previous hepatitis B virus infection and hepatocellular carcinoma risk in steatotic liver disease.

|May 06, 2026
Prevalence and Prognostic Impact of the Coexistence of Cachexia and Sarcopenia in Patients With Chronic Liver Diseases.

|Dec 13, 2025
Soluble Cluster of Differentiation 14 as a Prognostic Marker in Decompensated Cirrhosis With Water Retention.

Masato Nakai, Masatsugu Ohara, Daisuke Yokoyama

|Nov 21, 2025
Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi-Center Real-World Study.

Federica Lo Prinzi, Federico Rossari, Antonio De Rosa

Pageof 9

Frequent Collaborators

19 joint publications

Naoki Kawagishi

14 joint publications

Kenichi Morikawa

6 joint publications

Naoya Sakamoto

5 joint publications

Koji Ogawa